Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure
Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatme...
Gespeichert in:
Veröffentlicht in: | Transplant international 2022-03, Vol.35, p.10108-10108 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 10108 |
---|---|
container_issue | |
container_start_page | 10108 |
container_title | Transplant international |
container_volume | 35 |
creator | Schulz, Martin S Gu, Wenyi Schnitzbauer, Andreas A Trebicka, Jonel |
description | Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients. |
doi_str_mv | 10.3389/ti.2022.10108 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2665109655</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</originalsourceid><addsrcrecordid>eNpVkc1LAzEQxYMoVqtHr7JHL1vz0Ww2F6EsVoVCD9ZzyCZZG9kmNckW_O_dflgqDMzA_HgzvAfAHYIjQkr-mOwIQ4xHCCJYnoErNCY4x5ix85N5AK5j_IIQ4pLCSzAglDI8LtgVeJ_ZjQnZIkgX1610SSbrXSZjJrPKB2dCTN6ZHjAyrYxLWeNDNlFdMvnc5dUyeGdVtleZStt2wdyAi0a20dwe-hB8TJ8X1Ws-m7-8VZNZrghiKVcMUYJRwSimFEuEMUSEM250gyjETc01xX1xxFmtYQE1LHVBNNelKmuqyBA87XXXXb0yWvXfBdmKdbArGX6El1b83zi7FJ9-IzjkvLegF3g4CAT_3ZmYxMpGZdreB-O7KHBRUAR5sUPzPaqCjzGY5ngGQbENQiQrtkGIXRA9f3_625H-c578Aj9-g9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2665109655</pqid></control><display><type>article</type><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</creator><creatorcontrib>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</creatorcontrib><description>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</description><identifier>ISSN: 1432-2277</identifier><identifier>ISSN: 0934-0874</identifier><identifier>EISSN: 1432-2277</identifier><identifier>DOI: 10.3389/ti.2022.10108</identifier><identifier>PMID: 35572467</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Health Archive</subject><ispartof>Transplant international, 2022-03, Vol.35, p.10108-10108</ispartof><rights>Copyright © 2022 Schulz, Gu, Schnitzbauer and Trebicka.</rights><rights>Copyright © 2022 Schulz, Gu, Schnitzbauer and Trebicka. 2022 Schulz, Gu, Schnitzbauer and Trebicka</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</citedby><cites>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35572467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schulz, Martin S</creatorcontrib><creatorcontrib>Gu, Wenyi</creatorcontrib><creatorcontrib>Schnitzbauer, Andreas A</creatorcontrib><creatorcontrib>Trebicka, Jonel</creatorcontrib><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><title>Transplant international</title><addtitle>Transpl Int</addtitle><description>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</description><subject>Health Archive</subject><issn>1432-2277</issn><issn>0934-0874</issn><issn>1432-2277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkc1LAzEQxYMoVqtHr7JHL1vz0Ww2F6EsVoVCD9ZzyCZZG9kmNckW_O_dflgqDMzA_HgzvAfAHYIjQkr-mOwIQ4xHCCJYnoErNCY4x5ix85N5AK5j_IIQ4pLCSzAglDI8LtgVeJ_ZjQnZIkgX1610SSbrXSZjJrPKB2dCTN6ZHjAyrYxLWeNDNlFdMvnc5dUyeGdVtleZStt2wdyAi0a20dwe-hB8TJ8X1Ws-m7-8VZNZrghiKVcMUYJRwSimFEuEMUSEM250gyjETc01xX1xxFmtYQE1LHVBNNelKmuqyBA87XXXXb0yWvXfBdmKdbArGX6El1b83zi7FJ9-IzjkvLegF3g4CAT_3ZmYxMpGZdreB-O7KHBRUAR5sUPzPaqCjzGY5ngGQbENQiQrtkGIXRA9f3_625H-c578Aj9-g9s</recordid><startdate>20220317</startdate><enddate>20220317</enddate><creator>Schulz, Martin S</creator><creator>Gu, Wenyi</creator><creator>Schnitzbauer, Andreas A</creator><creator>Trebicka, Jonel</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220317</creationdate><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><author>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Health Archive</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schulz, Martin S</creatorcontrib><creatorcontrib>Gu, Wenyi</creatorcontrib><creatorcontrib>Schnitzbauer, Andreas A</creatorcontrib><creatorcontrib>Trebicka, Jonel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transplant international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schulz, Martin S</au><au>Gu, Wenyi</au><au>Schnitzbauer, Andreas A</au><au>Trebicka, Jonel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</atitle><jtitle>Transplant international</jtitle><addtitle>Transpl Int</addtitle><date>2022-03-17</date><risdate>2022</risdate><volume>35</volume><spage>10108</spage><epage>10108</epage><pages>10108-10108</pages><issn>1432-2277</issn><issn>0934-0874</issn><eissn>1432-2277</eissn><abstract>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35572467</pmid><doi>10.3389/ti.2022.10108</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1432-2277 |
ispartof | Transplant international, 2022-03, Vol.35, p.10108-10108 |
issn | 1432-2277 0934-0874 1432-2277 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099355 |
source | DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Health Archive |
title | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A52%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20Transplantation%20as%20a%20Cornerstone%20Treatment%20for%20Acute-On-Chronic%20Liver%20Failure&rft.jtitle=Transplant%20international&rft.au=Schulz,%20Martin%20S&rft.date=2022-03-17&rft.volume=35&rft.spage=10108&rft.epage=10108&rft.pages=10108-10108&rft.issn=1432-2277&rft.eissn=1432-2277&rft_id=info:doi/10.3389/ti.2022.10108&rft_dat=%3Cproquest_pubme%3E2665109655%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2665109655&rft_id=info:pmid/35572467&rfr_iscdi=true |